We make high quality biologic medicines more accessible, more quickly. #InnovatingAccess
Samsung Bioepis is a leading biopharmaceutical company dedicated to making high-quality biologic medicines more accessible. With a strong commitment to innovation and quality, Samsung Bioepis is rapidly advancing healthcare solutions for a wide range of therapeutic areas. Located at Yeonsu-gu, Incheon 21987, KR, Samsung Bioepis focuses on developing biosimilar candidates that address critical needs in immunology, oncology, ophthalmology, hematology, nephrology, and endocrinology.
Samsung Bioepis is committed to innovation in product development. The company aims to become a world leader in the biopharmaceutical industry by expanding its reach and improving patient outcomes. With a strong foundation built on rigorous research and development, Samsung Bioepis strives to deliver effective and affordable treatment options.
Samsung Bioepis continues to expand its capabilities and therapeutic pipeline, solidifying its position as a key player in the global biopharmaceutical market. We invite the management team at Samsung Bioepis to further enhance your company’s visibility by creating a customized and exclusive company showcase and product listing on our platform.
Samsung Bioepis est une entreprise biopharmaceutique de premier plan qui se consacre à rendre les médicaments biologiques de haute qualité plus accessibles. Fort d'un engagement fort envers l'innovation et la qualité, Samsung Bioepis fait progresser rapidement les solutions de soins de santé pour un large éventail de domaines thérapeutiques. Situé à Yeonsu-gu, Incheon 21987, KR, Samsung Bioepis se concentre sur le développement de candidats biosimilaires qui répondent aux besoins critiques en immunologie, oncologie, ophtalmologie, hématologie, néphrologie et endocrinologie.
Samsung Bioepis s'engage en faveur de l'innovation dans le développement de produits. L'entreprise vise à devenir un leader mondial dans l'industrie biopharmaceutique en élargissant sa portée et en améliorant les résultats pour les patients. Forte d'une base solide fondée sur la recherche et le développement rigoureux, Samsung Bioepis s'efforce de fournir des options de traitement efficaces et abordables.
Samsung Bioepis continue de développer ses capacités et son pipeline thérapeutique, consolidant ainsi sa position d'acteur clé sur le marché biopharmaceutique mondial. Nous invitons l'équipe de direction de Samsung Bioepis à améliorer davantage la visibilité de votre entreprise en créant une vitrine d'entreprise et une liste de produits personnalisées et exclusives sur notre plateforme.
Compare Samsung Bioepis with 3 companies in Pharmaceutical-Manufacturing
| Comparison Field |
Samsung BioepisMain Company |
Bristol Myers SquibbView Profile |
CellaresView Profile |
APIView Profile |
|---|---|---|---|---|
|
Founded Year
|
— | 0 | 2019 | 2018 |
|
Company Size
|
— | 10,001+ | 51-200 | 51-200 |
|
City
|
Yeonsu-gu, Incheon | Lawrence Township, NJ | South San Francisco, California | Edmonton, Alberta |
|
Country
|
South Korea | United States | United States | Canada |
|
Skills & Keywords
Comparing with main company
|
21 Total Skills
Biopharmaceutical
Biosimilars
Immunology
Oncology
Ophthalmology
Hematology
Pharmaceutical Manufacturing
oncology
pharmaceutical
research & development
ophthalmology
science
immunology
biopharmaceutical
biosimilars
clinical trials
innovation
quality
healthcare
biotechnology
regulatory affairs
|
2 Total
2 Unique
Unique Skills:
great place to work
pharmaceuticals
|
8 Total
8 Unique
Unique Skills:
biotech
cell therapy
manufacturing
medicine
patient care
patients
+2
|
14 Total
14 Unique
Unique Skills:
cro
drug development
formulation
internships
market access
medicinal chemestry
+8
|
Other organizations in the same industry
This company is also known as